Skip to Main content Skip to Navigation
Master Thesis

Place du cannabis thérapeutique dans le traitement des douleurs chroniques, en route vers sa reconnaissance médicale ?

Abstract : The discovery of the endocannabinoid system in the 1990s has opened the way for medical cannabis. Three cannabinoid medicines are currently available in some countries for specific therapeutic indications: spastic pain of multiple sclerosis, chemotherapy-induced nausea and vomiting and anorexia in patients with HIV. The research progress and new therapeutic applications are growing, especially for chronic pain’s treatment. A large part of the population is affected with this pathology and cannabinoid’s use in chronic pain’s treatment has given important results in several preclinical and clinical studies. While in some countries such as Canada or United states, drugs derived from cannabis are available with a prescription in pharmacy for over 15 years, France appears to be lagging behind. However, French people say themselves to be ready to use cannabis-based medication if needed. These new treatments seem to be promising; however medical cannabis has still to overcome the political barrier which slows down its medical recognition.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [40 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-01674819
Contributor : Bu Carreire Université de Bordeaux <>
Submitted on : Wednesday, January 3, 2018 - 4:49:25 PM
Last modification on : Saturday, January 13, 2018 - 1:22:37 AM
Long-term archiving on: : Wednesday, May 2, 2018 - 9:22:43 PM

File

Pharmacie_2017_Sorin.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-01674819, version 1

Collections

Citation

Charlotte Sorin. Place du cannabis thérapeutique dans le traitement des douleurs chroniques, en route vers sa reconnaissance médicale ? . Sciences pharmaceutiques. 2017. ⟨dumas-01674819⟩

Share

Metrics

Record views

159

Files downloads

5413